首页> 美国卫生研究院文献>Marine Drugs >Effect of Oral Ingestion of Low-Molecular Collagen Peptides Derived from Skate (Raja Kenojei) Skin on Body Fat in Overweight Adults: A Randomized Double-Blind Placebo-Controlled Trial
【2h】

Effect of Oral Ingestion of Low-Molecular Collagen Peptides Derived from Skate (Raja Kenojei) Skin on Body Fat in Overweight Adults: A Randomized Double-Blind Placebo-Controlled Trial

机译:口服摄入来自冰鞋(Raja Kenojei)皮肤的低分子胶原蛋白肽对超重成年人体脂肪的影响:一项随机双盲安慰剂对照的试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Recent animal studies found the potential of a collagen peptide derived from skate skin to have anti-obesity effects through the suppression of fat accumulation and regulation of lipid metabolism. However, no studies have yet been performed in humans. Here, this very first human randomized, placebo-controlled, and double-blinded study was designed to investigate the efficacy and tolerability of skate skin collagen peptides (SCP) for the reduction of body fat in overweight adults. Ninety healthy volunteers (17 men) aged 41.2 ± 10.4 years with a mean body mass index of 25.6 ± 1.9 kg/m2 were assigned to the intervention group (IG), which received 2000 mg of SCP per day or to the control group (CG) given the placebo for 12 weeks and 81 (90%) participants completed the study. Changes in body fat were evaluated using dual energy X-ray absorptiometry as a primary efficacy endpoint. After 12 weeks of the trial, the percentage of body fat and body fat mass (kg) in IG were found to be significantly better than those of subjects in CG (−1.2% vs. 2.7%, p = 0.024 and −1.2 kg vs. 0.3 kg, p = 0.025). Application of SCP was well tolerated and no notable adverse effect was reported from both groups. These results suggest the beneficial potential of SCP in the reduction of body fat in overweight adults.
机译:最近的动物研究发现,源自滑冰皮肤的胶原蛋白肽具有通过抑制脂肪堆积和调节脂质代谢而具有抗肥胖作用的潜力。但是,尚未在人类中进行任何研究。在这里,这是第一项人类随机,安慰剂对照和双盲研究,旨在研究滑冰皮肤胶原蛋白肽(SCP)减少超重成年人体内脂肪的功效和耐受性。年龄为41.2±10.4岁,平均体重指数为25.6±1.9 kg / m 2 的90名健康志愿者(17名男性)被分配至干预组(IG),每组接受2000 mg SCP对照组或安慰剂组(CG)接受安慰剂治疗12天,有81位(90%)参与者完成了研究。使用双能X线吸收法作为主要功效终点,评估了体内脂肪的变化。在试验的12周后,发现IG中的体内脂肪百分比和体脂质量(kg)显着优于CG中的受试者(-1.2%对2.7%,p = 0.024和-1.2 kg对0.3公斤,p = 0.025)。 SCP的应用耐受性良好,两组均未报告明显不良反应。这些结果表明SCP在减少超重成年人体内脂肪方面具有有益的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号